Investors

In September of 2004, Sopherion Therapeutics, Inc. announced the completion of a $47 million Series B venture funding. The financing was led by TL Ventures and included the Sprout Group, ProQuest, Canaan Partners, HealthCap, NewSpring Ventures, L.P., Commerce Health Ventures, and Seaflower Ventures.

Sopherion Therapeutics, Inc. has been operating since 2001, and was initially funded through convertible bridge loans and subsequently through a $26M series A round of financing which was led by TL Ventures. HealthCap, ProQuest Investments, Johnson & Johnson Development Corporation, Intersouth Partners, Seaflower Ventures, and Connecticut Innovations Incorporated also participated.